Properties
Description
Dihydroeponemycin interferes with the proteasome’s ability to degrade proteins, thereby disrupting cellular processes in cancer cells, particularly multiple myeloma.
Molecular Formula
C20H36N2O6
Identity
Confirmed by NMR/HPLC/MS.
Applications
Dihydroeponemycin acts as a research tool to investigate the proteasome’s role in protein degradation and apoptosis due to its irreversible inhibition of proteasome activity.
